Search Results - sars-cov-2

PubPharm (22.927)

1

An overview of the development of pharmacotherapeutics targeting SARS-CoV-2

in: Drug discovery today | 2024

by Lucaj, T. | Hay, I. | Samarbakhsh, A. | +3

2

COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers : A clinical review

in: Vaccine: X | 2024

by Galgut, O. | Ashford, F. | Deeks, A. | +11

3

Postacute Sequelae of COVID (PASC or Long COVID) : An Evidenced-Based Approach

in: Open forum infectious diseases | 2024

by Griffin, D.

ErratumIn: Open Forum Infect Dis. 2024 Sep 05;11(9):ofae509. doi: 10.1093/ofid/ofae509. - PMID 39238844

4

Coronavirus Disease 2019 in Kidney Transplantation - A 2024 Update

in: Advances in kidney disease and health | 2024

by Abu Jawdeh, B. | Vikram, H.

5

Investigating the impact of Tocilizumab, Sarilumab, and Anakinra on clinical outcomes in COVID-19 : A systematic review and meta-analysis

in: International journal of cardiology. Heart & vasculature | 2024

by Jafari Abarghan, Y. | Heiat, M. | Jahangiri, A. | +7

6

Virus-Induced Host Chemokine CCL2 in COVID-19 Pathogenesis : Potential Prognostic Marker and Target of Anti-Inflammatory Strategy

in: Reviews in medical virology | 2024

by Ansari, A. | Ahmad, F. | Alam, M. | +7

7

Platelet dysfunction caused by differentially expressed genes as key pathogenic mechanisms in COVID-19

in: Minerva cardiology and angiology | 2024

by Tan, X. | Gao, X. | Zheng, H. | +4

8

Investigating the FLiRT variants of COVID-19 : Is it an emerging concern?

in: Pathology, research and practice | 2024

by Aden, D. | Zaheer, S.

9

Phytochemicals in antiviral drug development against human respiratory viruses

in: Drug discovery today | 2024

by Mehta, S. | Pradhan, R.

10

A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine

in: Vaccine | 2024

by Pather, S. | Charpentier, N. | van den Ouweland, F. | +11

1
2
3
4
5
6
7
8
9
10
11
Next »
[2293]